188 related articles for article (PubMed ID: 3313326)
1. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100.
Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A
Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326
[TBL] [Abstract][Full Text] [Related]
2. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
3. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS
Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic activation of p-nitrotoluene and trichloroethylene by rat-liver S9 or mouse-liver S9 fractions in Salmonella typhimurium strains (author's transl)].
Miyata R; Nohmi T; Yoshikawa K; Ishidate M
Eisei Shikenjo Hokoku; 1981; 99():60-5. PubMed ID: 7037091
[No Abstract] [Full Text] [Related]
5. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
6. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella.
Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W
J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249
[TBL] [Abstract][Full Text] [Related]
7. A study on the mutagenic effect of some Bulgarian drugs using the Salmonella/microsome test.
Dimitrova K; Ivanov V; Bogoeva M; Golovinsky E; Markov K
Acta Physiol Pharmacol Bulg; 1983; 9(4):31-6. PubMed ID: 6375259
[TBL] [Abstract][Full Text] [Related]
8. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction].
Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM
Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of promutagens by the unicellular green alga Chlamydomonas reinhardtii.
Podstavková S; Vlcek D; Miadoková E
J Environ Pathol Toxicol Oncol; 1997; 16(1):21-6. PubMed ID: 9256928
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
Pavlov IuI; Khromov-Borisov NN
Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclophosphamide mutagenicity by beta-carotene.
Belisario MA; Pecce R; Battista C; Panza N; Pacilio G
Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914
[TBL] [Abstract][Full Text] [Related]
12. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
13. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
Prival MJ; Mitchell VD
Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
[TBL] [Abstract][Full Text] [Related]
14. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide].
Fonshteĭn LM; Loknitskaia NN; Rotenberg IuS
Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219
[TBL] [Abstract][Full Text] [Related]
15. Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India.
Lakshmi B; Ajith TA; Sheena N; Gunapalan N; Janardhanan KK
Teratog Carcinog Mutagen; 2003; Suppl 1():85-97. PubMed ID: 12616600
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9.
Araki A; Muramatsu M; Matsushima T
Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472
[TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
18. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
Hales BF
Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
Araki A; Kamigaito N; Sasaki T; Matsushima T
Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of beta-glucuronidase in the Ames test.
Cerná M
Mutat Res; 1985 Jul; 143(3):169-72. PubMed ID: 3892278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
